Long-term outcomes after repeat doses of antenatal corticosteroids

New England Journal of Medicine

Volumn 357, Issue 12, 2007, Pages 1190-1198

  Wapner, Ronald J ^a,b,r   Sorokin, Yoram ^c   Mele, Lisa ^d   Johnson, Francee ^e   Dudley, Donald J ^f   Spong, Catherine Y ^g   Peaceman, Alan M ^h   Leveno, Kenneth J ⁱ   Malone, Fergal ^a   Caritis, Steve N ^j   Mercer, Brian ^k   Harper, Margaret ^l   Rouse, Dwight J ^m   Thorp, John M ⁿ   Ramin, Susan ^o   Carpenter, Marshall W ^p   Gabbe, Steven G ^q  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b DREXEL UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o UNIVERSITY OF TEXAS   (United States)

^p BROWN UNIVERSITY   (United States)

^q VANDERBILT UNIVERSITY   (United States)

^r NewYork Presbyterian Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; PLACEBO;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BLOOD PRESSURE; BODY SIZE; CEREBRAL PALSY; CHILD DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSAGE SCHEDULE COMPARISON; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PREMATURITY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; RISK ASSESSMENT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 34548833077     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa071453     Document Type: Article

References (34)

1. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
2. Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2003;3:CD003935.
3. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000;2:CD000065.
4. McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Aust N Z J Obstet Gynaecol 2003;43:101-6.
5. Quinlivan JA, Evans SF, Dunlop SA, Beazley LD, Newnham JP. Use of corticosteroids by Australian obstetricians - a survey of clinical practice. Aust N Z J Obstet Gynaecol 1998;38:1-7.
6. Brocklehurst P, Gates S, McKenzie-McHarg K, Alfirevic Z, Chamberlain G. Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK. Br J Obstet Gynaecol 1999; 106:977-9.
7. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement 2000;17:1-10.
8. Wapner RJ, Sorokin Y, Thom EA, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006;195:633-42.
9. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913-9.
10. Thom EA, Klebanoff MA. Issues in clinical trial design: stopping a trial early and the large simple trial. Am J Obstet Gynecol 2005;193:619-25.
11. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23.
12. Wei LJ, Lachin JM. Properties of urn randomization in clinical trials. Control Clin Trials 1988;9:345-64. [Erratum, Control Clin Trials 1989;10:following 126.]
13. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital and health statistics. Series 11. No. 246. Hyattsville, MD: National Center for Health Statistics, May 2002:1-190. (DHHS publication no. (PHS) 2002-1696.)
14. Roche AF, Mukherjee D, Guo SM, Moore WM. Head circumference reference data: birth to 18 years. Pediatrics 1987;79:706-12.
15. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
16. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-21.
17. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004;190:588-95.
18. Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria Cerbo R, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004;191:217-24.
19. Hasbargen U, Reber D, Versmold H, Schulze A. Growth and development of children to 4 years of age after repeated antenatal steroid administration. Eur J Pediatr 2001;160:552-5.
20. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1179-89.
21. Hack M, Taylor HG, Drotar D, et al. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age. Pediatrics 2005;116:333-41.
22. Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-F181.
23. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in premature infants: a follow-up study. Pediatrics 1998;101(5):E7.
24. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:15-21.
25. Barrington KJ. The adverse neurodevelopmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001;1:1.
26. Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol 2005;192:146-52.
27. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 1999;94:213-8.
28. Quinlivan JA, Archer MA, Evans SF, Newnham JP, Dunlop SA. Fetal sciatic nerve growth is delayed following multiple maternal injections of corticosteroids in sheep. J Perinat Med 2000;28:26-33.
29. Quinlivan JA, Dunlop SA, Newnham JP, et al. Repeated, but not single, maternal administration of corticosteroids delay myelination in the brain of fetal sheep. Prenat Neonatal Med 1999;4:47-55.
30. Dunlop SA, Archer MA, Quinlivan JA, Beazly LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med 1997;6:309-13.
31. Quinlivan JA, Beazley LD, Evans SF, Newnham JP, Dunlop SA. Retinal maturation is delayed by repeat, but not single, maternal injections of betamethasone in sheep. Eye 2000;14:93-8.
32. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990;53:157-67.
33. Rayburn WF, Christensen HD, Gonzales CL, Rayburn LA, Stewart JD. Effect of in utero exposure to betamethasone on motivation/anxiety testing in mice offspring. Neurotoxicol Teratol 1998;20:475-81.
34. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341:339-41. [Erratum, Lancet 1993;341:572.]